Biotechnology

Yield10 Bioscience

Yield10 Bioscience grants Nufarm commercial license to produce Omega-3 assets in canola seeds and signs memorandum of understanding for asset sale.

Yield10 Bioscience announces delisting from Nasdaq

Apellis Pharma

AMPLITECH GROUP INC. USD0.001 S/R 20/11/26 SER B

U-BX Tech

3 E Network Tech

PMGC

AMPLITECH GROUP INC. COM USD0.001 (S/R 18/07/2026)

Bullfrog AI

Jaguar Uranium

Texxon

Classover Holdings - Class B

Kiniksa Pharmaceuticals

MiMedx

Rigel Pharma

CapForce Inc.

OpGen

Vertex Pharma

Argenx

Alnylam Pharma

Beigene

Natera

Style Score

Growth Score

Revenue YoY

Net Profit YoY

Value Score

P/B Ratio

Dividend Ratio

Size Score

Market Cap Score

Market Cap

Revenue Score

Revenue

Multi Score

Profit Score

Profit Margin

Gross Margin

Total Assets YoY

Net Assets YoY

Cash Score

Cash Flow Margin

OCF YoY

Operating Score

Turnover

Debt Score

Gearing Ratio

Please note that a "Suspected value trap" is a stock that appears The stock looks financially sound and severely undervalued, but behind the low valuation is a long-term decline in business capacity or a serious financial crisis, or even the risk of bankruptcy in the short term.

Suspected value trap

Yield10 Bioscience(YTEN.US)

Yield10 Bioscience Stock Performance Chart